Cash Flow, Leverage and Firm Size as Determinants of Accrual Earnings Management: Evidence from Pharmaceutical Firms in Nigeria
International Journal of Research in Social Science and Humanities · 2026 · 07 (06) · 279-286
DOI: 10.47505/ijrss.2026.6.22 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Research in Social Science and Humanities, 2026. Verfasst von Aferokhe Endurance und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Purpose
This paper examines whether cash flow from operations, financial leverage, and firm size explain discretionary accruals in Nigerian pharmaceutical firms under IFRS. We test the debt covenant and political cost hypotheses in an emerging market with weak investor protection and monetary tightening. Design/methodology/approach: Using panel data from seven pharmaceutical firms listed on the Nigerian Exchange Group from 2016 to 2025, we estimate discretionary accruals via the Modified Jones Model with performance matching. Panel Random Effects regression with White cross-section robust standard errors tests whether CFO, LEV, and SIZE predict discretionary accruals.
Findings
Cash flow from operations has a significant negative effect on discretionary accruals (β = -1.91E-11, p < 0.01). Financial leverage has an insignificant positive effect (β = 0.020, p > 0.10), rejecting the debt covenant hypothesis. Firm size has a significant positive effect (β = 0.035, p < 0.05), contrary to the predicted negative effect under the political cost hypothesis. Audit quality is also insignificant. Research limitations/implications: The sample is limited to seven listed firms due to data availability. Future research should incorporate corporate governance variables and real earnings management measures. Practical implications: The Financial Reporting Council of Nigeria should strengthen audit oversight, as Big 4 audit presence does not constrain earnings management. Monetary policy tightening may indirectly affect financial reporting quality by increasing financial distress. Originality/value: This is among the first studies to test the joint effect of CFO, LEV, and SIZE on discretionary accruals in Nigeria’s pharmaceutical sector under IFRS.
Zitieren
APA
Endurance, A., James, A., Chukwu, N. C., & Andrew, J. (2026). Cash Flow, Leverage and Firm Size as Determinants of Accrual Earnings Management: Evidence from Pharmaceutical Firms in Nigeria. International Journal of Research in Social Science and Humanities, 07(06), 279-286. https://doi.org/10.47505/ijrss.2026.6.22
Vancouver
Endurance A, James A, Chukwu NC, Andrew J. Cash Flow, Leverage and Firm Size as Determinants of Accrual Earnings Management: Evidence from Pharmaceutical Firms in Nigeria. International Journal of Research in Social Science and Humanities. 2026;07(06):279-286. doi:10.47505/ijrss.2026.6.22
BibTeX
@article{Endurance2026,
author = {Endurance, Aferokhe and James, Apemiye and Chukwu, Nkeiruka Claris and Andrew, Joshua},
title = {Cash Flow, Leverage and Firm Size as Determinants of Accrual Earnings Management: Evidence from Pharmaceutical Firms in Nigeria},
journal = {International Journal of Research in Social Science and Humanities},
year = {2026},
volume = {07},
number = {06},
pages = {279--286},
doi = {10.47505/ijrss.2026.6.22}
}
EUVIMED